Accrol Group Holdings Interim results presentation - January 2023

Accrol, CEO Gareth Jenkins, CFO, Richard Newman & Group Financial Controller (and CFO designate), Chris Welsh, present the interim results for the six months ended 31 October 2022.

"There was strong progress across all businesses and products. The Group has performed well in H2 to date and is on track to achieve revenue and adjusted EBITDA growth for the year ending 30 April 2023 ("FY23") marginally ahead of expectations at £230m and £15.5m respectively."

Gareth Jenkins, CEO
00:16 - Introduction
00:34 - HY22/23 Performance summary

Richard Newman, CFO
02:33 - Market and revenue overview
03:47 - HY22/23 Financial summary
07:21 - Half year commercial highlights
08:28 - Half year operational highlights

Gareth Jenkins, CEO
09:12 - ESG summary
11:22 - FY23 outlook
12:47 - Strategic review

Chris Welsh, Group Financial Controller (and CFO designate)
16:55 - Strategic review continued

Gareth Jenkins, CEO
18:29 - Summary

20:11 - Q&A

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate volumes totalling c.21.5% of the c£2.5bn UK retail tissue market.

For more information, please visit www.accrol.co.uk.